Pervol Injection 15 Milligrams (Polinonate Calcium)
Calcium Folinate 16mg
Prescription medication
Samjin Pharmaceutical Co., Ltd.
MFDS item code 198901292 · Notified 1989.06.21 · Insurance code 647802491
Relief of toxicity from folate antagonists; treatment of advanced colorectal cancer in combination with 5-FU
This medication helps to reduce the toxicity that may occur when using folate metabolic antagonists, thereby alleviating the burden on patients. Additionally, it aids in enhancing the therapeutic effect when used with 5-Fluorouracil (5-FU) in the treatment of progressive colon cancer. Such efficacy can be expected from both the injection and tablet forms of this medication. Therefore, it plays a significant role in reducing side effects and improving therapeutic efficacy during cancer treatment.
(Injection) 1. Conventional methotrexate therapy: If adverse reactions occur with the usual dose of methotrexate (a folic acid antagonist), administer 6-12mg of folinate per dose by intramuscular injection every 6 hours, 4 times daily. In the event of methotrexate overdose, administer an amount equal to the dose of methotrexate taken. 2. Methotrexate-folinate rescue therapy: Starting 3 hours after completion of methotrexate administration, administer 15mg of folinate per dose by intravenous injection every 3 hours for 9 doses, followed by intravenous or intramuscular injection every 6 hours for 8 doses. If severe adverse reactions considered to be caused by methotrexate occur, increase the dose and extend the duration of treatment. 3. Concomitant administration with 5-Fluorouracil (5-FU) for advanced colorectal cancer: Select one of the two regimens. 1) Administer 200mg/㎡ of calcium folinate per day slowly by intravenous injection over at least 3 minutes, followed by intravenous injection of 370mg/㎡ of 5-FU. 2) Administer 20mg/㎡ of calcium folinate per day by intravenous injection, followed by intravenous injection of 425mg/㎡ of 5-FU. Do not administer them simultaneously, as precipitation of 5-FU and folinate may occur. Continue the above treatment for 5 days and repeat it at 4-week intervals. (Tablets) In the event of an overdose of a folic acid antagonist (e.g., methotrexate), administer 10mg of folinate per m2 of body surface area orally every 6 hours as soon as possible (within 1 hour after the overdose) to reduce the serum methotrexate concentration to 10-8M/L or less. If gastrointestinal toxicity, nausea, or vomiting occurs, administer folinate parenterally. Analyze serum every 24 hours to determine the creatinine and methotrexate concentrations. If the serum creatinine concentration 24 hours later has increased by 50% compared with before methotrexate administration, or if the serum methotrexate concentration 24 hours later is 5X10-6M/L or higher, administer a high dose of calcium folinate. As oral administration of 25mg or more is not recommended, administer it parenterally. Provide fluids to maintain urine output of 1800-2000mL/㎡ per day, while alkalinizing the urine with sodium bicarbonate (maintain urine pH at 7.0 or higher) to increase the solubility of methotrexate and its metabolites until the methotrexate level reaches 5×10-8M/L (0.05μM/L).
This medication is not suitable for the treatment of pernicious anemia or megaloblastic anemia due to Vitamin B12 deficiency. While neurological symptoms may continue to progress, improvement in blood conditions may also occur, warranting caution. Care must be taken when opening the ampule as glass fragments may enter, particularly when administering to children or the elderly. Pregnant or breastfeeding women should not use this medication in combination with 5-FU, and should use it cautiously if administered alone. Severe allergic reactions such as hives or anaphylaxis may occur due to hypersensitivity; notify medical personnel immediately if unusual symptoms arise. Pain or temporary discomfort may occur at the injection site, and rare instances of fever or central nervous system symptoms may also present. When combined with other anticancer agents, side effects such as diarrhea, skin problems, and stomatitis may arise, necessitating dosage adjustment if symptoms are severe. This medication should be used under the guidance of a specialist, especially during methotrexate treatment, monitoring blood concentration to determine appropriate dosage and treatment duration. Caution is required as drug excretion may be delayed in cases of renal function impairment or fluid retention in the body. There are interactions between this medication and certain anticonvulsants that may increase the risk of seizures, thus dosage should be adjusted while monitoring blood concentrations. Elderly or physically weak patients may have a higher risk of gastrointestinal side effects, requiring special attention. This medication is contraindicated for intrathecal administration, and when administered intravenously, the injection speed should be controlled due to calcium content. Store out of reach of children and keep in the original container to maintain safety and efficacy.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to light, so it should be stored in an airtight container that blocks light. It is recommended to maintain the storage temperature at room temperature, avoiding excessive heat or cold.
A colorless to light yellow transparent injection solution in a brown ampoule
1mL - 50 ampoules/box
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Calcium Folinate 16mg
Prescription medication
Samjin Pharmaceutical Co., Ltd.
Calcium Folinate 3.2mg
Prescription medication
Samjin Pharmaceutical Co., Ltd.

Calcium Folinate 5.4mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Calcium Folinate 106.7mg
Prescription medication
Samjin Pharmaceutical Co., Ltd.
Calcium Folinate 32mg
Prescription medication
Samjin Pharmaceutical Co., Ltd.
Calcium Folinate 53.4mg
Prescription medication
Samjin Pharmaceutical Co., Ltd.
Calcium Folinate 16.2mg
Prescription medication
Korea Pfizer Pharmaceutical Co., Ltd.
Calcium Folinate 10.8mg
Prescription medication
Korea Pfizer Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.